The United Kingdom is witnessing a remarkable evolution in its attitude towards mind-altering substances. What began with a quiet exploration of psilocybin and classic ceremonial brews is now broadening to encompass more experimental substances like copyright and potentially studies into therapeutic uses. This burgeoning interest is powered by grow